COGT (Cogent Biosciences) Institutional Ownership: 115.94% (As of Jul. 07, 2026)


COGT Cogent Biosciences Inc COGT
25 GF Score
Price $40.09
! 4 Warning Signs
View Full Analysis

What is Cogent Biosciences Institutional Ownership?

Cogent Biosciences COGT +1.66% 25 Institutional Ownership is 115.94% as of Jul. 07, 2026. GuruFocus rates COGT with a GF Score™ of 25/100. The stock has 4 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Cogent Biosciences's institutional ownership is 115.94%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Cogent Biosciences's Insider Ownership is 3.70%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Cogent Biosciences's Float Percentage Of Total Shares Outstanding is 99.43%.

Cogent Biosciences Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Cogent Biosciences's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cogent Biosciences Institutional Ownership Chart

Cogent Biosciences Historical Data

The historical data trend for Cogent Biosciences can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 42.57 42.09 42.01 48.19 51.54 52.77 56.85 56.87 57.25 58.53
COGT
25GF Score
Cogent Biosciences Inc COGT
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cogent Biosciences Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 115.94% mean?
Cogent Biosciences (COGT) has a Institutional Ownership of 115.94% as of Jul. 07, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Cogent Biosciences and its competitors.
Is Cogent Biosciences' Institutional Ownership too high?
Cogent Biosciences' current Institutional Ownership is 115.94%. Overall, Cogent Biosciences has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Cogent Biosciences' Institutional Ownership compare to SRRK and CGON?
Cogent Biosciences' Institutional Ownership of 115.94% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Cogent Biosciences and its competitors. Cogent Biosciences's current Institutional Ownership is 115.94%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cogent Biosciences stock overvalued right now?
Cogent Biosciences (COGT) has a current Institutional Ownership of 115.94%. The current Institutional Ownership is 115.94%. Cogent Biosciences' overall GF Score™ is 25/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Cogent Biosciences (COGT), the current Institutional Ownership is 115.94% as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cogent Biosciences Business Description

Address 275 Wyman Street, 3rd Floor, Waltham, MA, USA, 02451
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
25GF Score

Get the complete analysis for COGT

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$40.09
Price